Journal article
Why is pre-exposure prophylaxis with hydroxychloroquine a safe and rationale approach against SARS-CoV-2 infection?
Abstract
The potentiality of Hydroxychloroquine (HCQ) for pre-exposure prophylaxis against SARS-CoV-2 has not been explored in randomized controlled trials. However, there is rationale behind this potentiality in terms of demonstrated in-vitro effect of HCQ against SARS-CoV-2, safety profile of HCQ in healthy individuals and a recent observational study demonstrating benefits of HCQ prophylaxis in terms of a significant reduction (>80%) in the odds of …
Authors
Mehta S; Bhandari S; Mehta S
Journal
Journal of Global Antimicrobial Resistance, Vol. 22, , pp. 864–865
Publisher
Elsevier
Publication Date
9 2020
DOI
10.1016/j.jgar.2020.07.022
ISSN
2213-7165